A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years

OBJECTIVE: We performed a randomised trial in very preterm, small for gestational age (SGA) babies to determine if prophylaxis with granulocyte macrophage colony stimulating factor (GM-CSF) improves outcomes (the PROGRAMS trial). GM-CSF was associated with improved neonatal neutrophil counts, but no...

Descripción completa

Detalles Bibliográficos
Autores principales: Marlow, Neil, Morris, Timothy, Brocklehurst, Peter, Carr, Robert, Cowan, Frances, Patel, Nishma, Petrou, Stavros, Redshaw, Margaret, Modi, Neena, Doré, Caroline J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484494/
https://www.ncbi.nlm.nih.gov/pubmed/25922190
http://dx.doi.org/10.1136/archdischild-2014-307410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484494/
https://www.ncbi.nlm.nih.gov/pubmed/25922190
http://dx.doi.org/10.1136/archdischild-2014-307410

Ejemplares similares